FDA Bovine-Derived Supplement, BSE Actions Under Congressional Scrutiny
This article was originally published in The Tan Sheet
Executive Summary
Two senior House Democrats seek FDA information on its efforts to track and control bovine-derived dietary supplement products that may be susceptible to potential BSE contamination in a Jan. 31 letter to Acting Commissioner Bernard Schwetz, PhD.